API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Clinical Research of Atomoxetine hydrochloride

Atomoxetine hydrochloride, a nonstimulant approved by the US Food and Drug Administration for the treatment of ADHD.

Dec 30,2025  API

Biosynthesis and Biological Activity of ADP

ADP stores energy through phosphorylation to form adenosine triphosphate (ATP) and releases energy for cellular activities upon ATP hydrolysis.

Dec 30,2025  API

Preparation and Biological Activity of Diethyl maleate

Diethyl maleate can be prepared by the esterification of maleic anhydride with ethanol in the presence of sulfuric acid.

Dec 30,2025  API

Synthesis and Approval Status of Epinephrine Hydrochloride

Epinephrine Hydrochloride was nominated for inclusion on the 503B Bulks List due to its broad therapeutic applicability across multiple medical conditions.

Dec 30,2025  API

Synthesis and Medical Application of 3-Amino-1-Hydroxyadamantane

In the field of chemical synthesis, 3-Amino-1-Hydroxyadamantane serves primarily as a key synthetic intermediate for the pharmaceutical molecule Vildagliptin.

Dec 30,2025  API

The Synthesis of Cinnamic Acid

Cinnamic acid can be synthesised with high yields and selectivities via Knoevenagel, Perkin, Pechman, Reformatsky, and Wittig reactions using various catalysts, alongside a range of waste reduction an

Dec 29,2025  API

Bis(2-ethylhexyl) Maleate: Toxicological Profile and Reaction Kinetics

Bis(2-ethylhexyl) maleate shows toxic metabolite accumulation and glutathione stress response; it undergoes Diels-Alder reaction with cyclopentadiene.

Dec 29,2025  API

Vinyl Terminated Polydimethylsiloxane: Synthesis Strategies & Applications

Vinyl terminated polydimethylsiloxane is synthesized via alkoxysilane polycondensation/ring-opening copolymerization and used to prepare PTFE.

Dec 29,2025  API

Ginsenoside Re: Diverse Pharmacological Properties

Ginsenoside Re exerts anti-inflammatory/neuroprotective effects, undergoes deglycosylation/oxidation metabolism, and enhances health.

Dec 29,2025  API

Wogonin: Flavonoid from Scutellaria baicalensis

Wogonin inhibits EBV-positive lymphoma via NF-κB pathway, exerts neuroprotection in cerebral ischemia, and targets CNS/degenerative diseases.

Dec 26,2025  API
Prev12345678910...Next>  Go to Page